Efficacious and safe management of type 2 diabetes mellitus using DPP-4 inhibitors
Diabetes mellitus (DM) is believed to be the third most frequent direct cause of death after cardiovascular and oncological diseases. Therefore, solutionof DM-related problems is a major challenge facing health authorities in many countries. No doubt, strict control of glycemia is an indispensableco...
Main Authors: | Alexander Sergeevich Ametov, Ekaterina Vladimirovna Karpova |
---|---|
Format: | Article |
Language: | English |
Published: |
Endocrinology Research Centre
2010-06-01
|
Series: | Сахарный диабет |
Subjects: | |
Online Access: | https://www.dia-endojournals.ru/jour/article/view/5677 |
Similar Items
-
Galvus and Galvus Met, new registered medicinal agents for the treatment of diabetes mellitus
by: Editorial team Diabetes Mellitus
Published: (2009-06-01) -
Vildagliptin and its role in the treatment of diabetes mellitus
by: Yury Shavkatovich Khalimov
Published: (2010-09-01) -
Rannyaya kombinirovannaya terapiya pri sakharnom diabete 2 tipa
by: Alexander Sergeevich Ametov, et al.
Published: (2011-09-01) -
Expert committee on novel DPP-4 inhibitor TRADJENTA (linagliptin) in treatment of type 2 diabetes mellitus
by: Editorial team Diabetes Mellitus
Published: (2012-06-01) -
The efficacy of therapy with DPP-4 inhibitors combined with insulin in patients with type 2 diabetes mellitus
by: Alexander Sergeevich Ametov, et al.
Published: (2011-12-01)